The bitter taste receptor T2R38 is not only on the tongue. It also lines the sinuses, where it detects bacterial signalling molecules and answers with nitric oxide — and the genotype that tastes nothing defends the sinuses less well.
Chronic rhinosinusitis is inflammation of the nose and sinuses lasting more than twelve weeks: a blocked nose, discharge, facial pressure and a reduced sense of smell that do not resolve. It is common, and for a minority of people it is stubborn — it comes back after treatment, sometimes after surgery.
The reason it has a page on a genetics site is one of the more surprising findings in recent human biology. The receptor that decides whether broccoli tastes bitter is also on the cells lining your sinuses.
TAS2R38 was found on the apical surface of the sinonasal epithelium — the layer facing the airway, on the cilia that sweep mucus out of the sinuses. It is not there to taste anything. It is there to eavesdrop.
Gram-negative bacteria coordinate with each other by secreting small molecules, a process called quorum sensing: each cell releases a signal, and when enough of them are present the population switches on the genes for forming a biofilm. Those signalling molecules happen to be shaped like something T2R38 binds. So the receptor detects a bacterial conversation before the bacteria act on it, and it answers immediately: calcium signal, nitric oxide production, faster ciliary beating, and nitric oxide diffusing into the airway fluid where it damages the bacteria directly.
This is the same receptor, the same three coding changes, and the same taster and non-taster forms described on the bitter taste page. Cells from PAV/PAV people — the strong tasters — produced much more nitric oxide and killed bacteria more efficiently than cells from AVI/AVI non-tasters. And the polymorphisms that make the receptor work or not appear to be involved in susceptibility to upper respiratory infection and to recalcitrant chronic rhinosinusitis.
Because it closes a loop this site is built on. The same position in the genome that decides whether a vegetable is bitter also plays into how the sinuses defend themselves, and into whether a bitter medicine is swallowed or spat out. One base, three different kinds of consequence — that is not a metaphor here, it is the same three variants read three ways.
It does not mean non-tasters get sinus infections and tasters do not. The effect sits alongside allergy, anatomy, asthma, smoking and everything else that drives this disease, and no guideline anywhere uses taste genotype to diagnose sinusitis, choose treatment or decide on surgery. If you have symptoms that have lasted more than twelve weeks, that is a reason to see a doctor whatever your genotype is.
Definition. Chronic rhinosinusitis is defined by inflammation of the nose and paranasal sinuses persisting beyond twelve weeks, with two or more of nasal blockage, nasal discharge, facial pain or pressure and reduction or loss of smell, supported by endoscopic or CT findings. It is subclassified by the presence or absence of nasal polyps, and increasingly by inflammatory endotype rather than phenotype alone.
T2R38 in the airway. TAS2R38 is expressed on the apical membrane of ciliated sinonasal epithelial cells. Acyl-homoserine lactones — quorum-sensing molecules of gram-negative bacteria including Pseudomonas aeruginosa — activate the receptor, triggering a calcium signal, nitric oxide synthase-dependent NO production, increased ciliary beat frequency and mucociliary transport, and direct bactericidal activity of NO diffusing into the airway surface liquid. Mature cilia are required for receptor expression and function. In primary human sinonasal air-liquid interface cultures, PAV/PAV homozygotes generated substantially greater NO and more efficient bacterial killing than AVI/PAV heterozygotes or AVI/AVI homozygotes (Lee RJ et al., J Clin Invest 2012;122:4145-59, PMID 23041624; reviewed in Cohen NA, Laryngoscope 2017;127:44-51, PMID 27650657).
Clinical association. The polymorphisms underlying T2R38 functionality appear to contribute to susceptibility to upper respiratory infection and to recalcitrant chronic rhinosinusitis, and the non-taster genotype has been reported as an independent risk factor for CRS requiring surgery and for poorer post-operative quality-of-life gain. These are association studies in surgical populations, not prospective genotype-stratified trials, and TAS2R38 genotyping has no role in diagnosis, endotyping, medical management or surgical decision-making.
Relationship to the taste phenotype. The haplotype structure, strand caution and effect sizes are identical to those described on the bitter taste perception page — this is the same gene and the same three variants, differing only in which tissue is being considered. A reader's diplotype means the same thing in both places.
What a 23andMe/AncestryDNA export or raw VCF can and can't tell you about Chronic Rhinosinusitis and the Bitter Taste Receptor comes down to these specific, well-studied positions — not a diagnosis.
Research-derived gene–drug associations only — not a prescription, dosing guide, or medical advice. Always follow your prescriber's guidance.
| Gene | Drug | What the research shows |
|---|---|---|
| TAS2R38 | Bitter oral medicines (chloramphenicol, ofloxacin and other bitter drugs) | This is about whether a medicine can be swallowed, not about how it is handled once it is. TAS2R38 genotype changes how bitter a bitter drug tastes, and in a retrospective analysis of 448 children, those carrying at least one bitter-sensitive allele (PP or AP) were more likely to have taken medication in solid form than bitter-insensitive (AA) children — a liquid that tastes intensely bitter tends to be refused. A later study found the differing bitterness of chloramphenicol and ofloxacin was explained by TAS2R38 diplotype and a TAS2R9 variant respectively. No guideline uses genotype to choose a formulation; this explains a real difficulty rather than instructing anyone. (Lipchock SV, Reed DR, Mennella JA, Clin Ther 2012;34:728-33, PMID 22440514; Front Genet 2022;13:960154, PMID 35967977) |
It is not tasting anything there. Gram-negative bacteria coordinate with each other by releasing signalling molecules, and those molecules happen to activate this receptor. So it works as a sentinel: it detects the bacterial conversation and answers with nitric oxide, which speeds up the cilia sweeping mucus out and damages the bacteria directly.
No. The effect sits alongside allergy, anatomy, asthma, smoking and everything else that drives this disease. What research reports is that the non-functional receptor form is associated with susceptibility to upper respiratory infection and with sinusitis that resists treatment — an association in surgical populations, not a prediction about you.
No. No guideline uses taste genotype to diagnose sinusitis, choose treatment or decide on surgery. Symptoms lasting more than twelve weeks deserve medical assessment regardless of genotype.
The same gene and the same three variants, read in a different tissue. Your diplotype means the same thing in both places — PAV builds a receptor that responds strongly, AVI one that barely responds — and here that response happens in the sinuses rather than on the tongue.
Free to reuse. This page's text is original writing from freely-available research, licensed CC BY 4.0 — reuse it, including commercially, with attribution to MyGeneLog. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.